ScholarIQanswers from OpenAlex

Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy

PaperCitations, authors & open-access status

Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy have?

ScholarIQcitation count

Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy has 15 citations in the OpenAlex counts ScholarIQ stores.

When was Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy published?

ScholarIQyear

Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy has 2023 year in the ScholarIQ index.

What is the open-access status of Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy?

ScholarIQoa status

Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy has gold oa status in the ScholarIQ index.

What is the DOI of Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy?

ScholarIQdoi

The DOI for Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy is on the source record.

What is the PMID of Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy?

ScholarIQpmid

The PMID for Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy is on the source record.

What is the OpenAlex record for Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy?

ScholarIQopenalex

The OpenAlex for Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial